Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer

Klarenbach et al discuss the recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. This guideline updates the task force's previous recommendations for primary care providers on breast cancer screening for women aged 40 to 74 y...

Full description

Saved in:

Bibliographic Details
Published in:	Canadian Medical Association journal (CMAJ) 2018-12, Vol.190 (49), p.E1441-E1451
Main Authors:	Klarenbach, Scott, MD MSc, Sims-Jones, Nicki, RN MScN, Lewin, Gabriela, MD, Singh, Harminder, MD MPH, Thériault, Guylène, MD, Tonelli, Marcello, MD SM, Doull, Marion, PhD, Courage, Susan, RN BScN, Garcia, Alejandra Jaramillo, MSc, Thombs, Brett D., PhD
Format:	Article
Language:	eng
Subjects:	Adult Aged Analysis Anopheles Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - diagnostic imaging Canada Cancer Cancer diagnosis Cancer screening Cancer treatment Clinical decision making Decision making Diagnosis Early Detection of Cancer - methods Female Guideline Health aspects Health risk assessment Humans Internal Medicine Magnetic resonance imaging Mammography - methods Medical screening Middle Aged Mortality Practice guidelines (Medicine) Risk Assessment Risk factors Systematic review Time Factors Women Women's health Womens health
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Klarenbach et al discuss the recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. This guideline updates the task force's previous recommendations for primary care providers on breast cancer screening for women aged 40 to 74 years who are not at increased risk of breast cancer. Those considered to be at increased risk include women with a personal or family history of breast cancer; women who are carriers of gene mutations such as BRCA1 or BRCA2, or who have a first-degree relative with these gene mutations; and women who had chest radiation therapy before age 30 years or within the past 8 years.
ISSN:	0820-3946 1488-2329